David Hughes
CHIEF TECHNOLOGY OFFICER
Clinical Development
cnBIO Innovations
Romania
Biography
Dr Hughes is Principle Investigator on a $26Mi US Defence Advanced Research Projects Agency (DARPA) contract towards development of human in vitro multi-organ platforms and leads a €4Mi EU FP7 program aimed at developing stem cell derived models of human liver. Before joining CN Bio, he spent three years working in manufacturing and research and development at GlaxoSmithKline. Dr Hughes graduated from the University of Oxford with a Masters in Engineering Science and Doctorate in Chemical Engineering.Dr Hughes was promoted to Chief Technology Officer in July 2014 with responsibility for managing the technical programs with the company’s academic and industrial partners. Dr Hughes joined CN Bio Innovations in 2010 as Head of Engineering and was promoted to Technical Director in 2013 with responsibility for the management of all in-house and collaborative research and development programmes and the contract research services business. During his career at CN Bio, he has secured and overseen the successful delivery of government and pharmaceutical research contracts and research grants totaling more than £2Mi.
Research Interest
Developing Stem cell derived models of Human liver
